However, in CLL, an imbalance of soluble BAG6 in plasma and on the sEV surface compared to CLL B-cell surface may aid in immune evasion due to a lack of surface BAG6 essential for malignant cell targeting (121). Here, BAG6 is linked to B-cell chronic lymphocytic leukemia.